Metabolomics 2025
Prague, Czech Republic
Overview
We are excited to invite you to the 21th Annual International Conference of the Metabolomics Society which will take place from June 22 - 26, 2025 at the Prague Congress Center in Prague, Czech Republic.
Come and visit booth No. P4 and get a free drink voucher for the Bruker bar on June 24 at the U Medvídků, Na Perštýně 7, 100 01 Praha 1, Czech Republic.
Please join Bruker’s Lunch seminar in Room South Hall 2 at 12:20 on June 25!
We are looking forward to meeting you in Prague!
Registration for the lunch seminar will be done by the conference organization.
You need to be registered for the conference to attend our lunch seminar.
Addressing frontier challenges in metabolomics with innovative technologies
Wednesday, June 25, 2025
12:20 - 1:20 pm CEST
Room: South Hall 2
Join us in Prague for an engaging lunch seminar to discover how TIMS MS and NMR technologies are helping leading researchers tackle challenges in metabolomics research.
Discover how scientific curiosity drives innovation in the pursuit of deeper profiling and more confident metabolite annotation. Dr. Witting is exploring new ways to utilize trapped ion mobility spectrometry (TIMS) to identify lipids and metabolites in C. elegans and human samples. Dr. Trautwein will discuss how NMR and MS enable biomarker discovery and quantitation in cancer and metabolic disorders.
Presentations:
- TIMS-enabled Lipidomics: Explore high-sensitivity lipidomics with PD
Michael Witting, Ph.D., Deputy Head Metabolomics and Proteomics Core and Executive Manager Metabolomics, Helmholtz Munich, Munich, Germany - LC- and NMR-supported Metabolomics: Discover groundbreaking data and insights
Christoph Trautwein, Ph.D., Head of Core Facility/Research Group Leader, Core Facility Metabolomics, Faculty of Medicine M3 Center for Malignome, Metabolome and Microbiome, University Hospital Tübingen, Tübingen, Germany
Michael Witting, Ph.D., Deputy Head Metabolomics and Proteomics Core and Executive Manager Metabolomics, Helmholtz Munich, Munich, Germany
Christoph Trautwein, Ph.D., Head of Core Facility/Research Group Leader, Core Facility Metabolomics, Faculty of Medicine, M3 Center for Malignome, Metabolome and Microbiome, University Hospital Tübingen, Tübingen, Germany
Disclaimer
As you are certainly aware, special compliance regulations apply to public officials* and healthcare professionals** with regard to the event we are planning. If you accept our invitation, we will therefore assume that you will observe the compliance regulations that apply to you and that you have the necessary employer approval.
* Government Official means according the Bruker policies any of the following: any officer, employee or representative of a government (national, regional or local) entity, or any public agency, public authority, department or instrumentality thereof, regardless of their rank or title (e.g. a regulatory official or government inspector); any person working for or advising a government-owned or government-controlled enterprise (e.g. a professor at a government-owned university, or a purchaser at a government-owned hospital); any person working for or advising a national or international non-governmental organization (e.g. an employee of the Red Cross or The World Bank); any person performing a public function or providing a public service, even if that person works for a nongovernmental institution (e.g. private security personnel working in public functions); any person hired to review or accept bids for a government agency; any person with the responsibility to allocate or expend government funds; any person in a public law function, civil servant, judge or military personnel; any person acting for a political party, including party officials, candidates or individuals holding a position in a political party office; members of royal families; or immediate family members of any of the persons listed above. An immediate family member is a grandparent, parent, spouse, significant other, child, or sibling.
** A Healthcare Professional (HCP) is in accordance with the Bruker policies any physician, dentist, nurse, pharmacist or other individual who may prescribe, administer, purchase, dispense, recommend, or supply medical products or treatments or pharmaceutical products. In many cases, Bruker interacts with HCPs who work for state-owned hospitals (e.g. as medical scientists). These individuals will be classified as both HCPs and Government Officials.
For Research Use Only. Not for use in clinical diagnostic procedures.